Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Structural differences between SARS-CoV-1 and SARS-CoV-2 RBDs

A new study compares the SARS-CoV-2 RBD to the SARS-CoV RBD using computational methods to understand their binding affinities to ACE2.

13 Apr 2022

Novel transdermal vaccine delivery for COVID-19 and cancer

Researchers assess the efficacy of a fluorocarbon modified chitosan system for the development of SARS-CoV-2 vaccines and tumor immunotherapy.

13 Apr 2022

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

A new study has stated that the third booster dose of mRNA-based COVID-19 vaccines is 68% effective in preventing reinfection-related hospitalization among persons with a history of SARS-CoV-2.

13 Apr 2022

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

A recent scientific statement published in Circulation reviewed the current knowledge on COVID-19.

13 Apr 2022

Impact of COVID-19 infection and vaccination on antibody response

A new study assessed the impact of COVID-19 and vaccination on antibody responses.

13 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

In a new study, researchers devised a method for reducing the size of a large collection of SARS-CoV-2 genomes by combining correlated single nucleotide variation sets with allelic association.

13 Apr 2022

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

A recent study assessed the efficacy of the second and third doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccines against the SARS-CoV-2 Omicron and Delta variants in outpatient settings.

13 Apr 2022

Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers demonstrated the evolution of multi-system inflammatory syndrome in children (MIS-C) following acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

12 Apr 2022

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-specific cluster of differentiation 8 (CD8+) T cell responses.

12 Apr 2022

Study shows significant increase in breastfeeding during COVID

In a recent study under consideration at the BMC Pregnancy and Childbirth journal and posted to the Research Square* preprint server, researchers described the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced pandemic on mother-baby dyads immediately after the first wave of the pandemic, i.e., between March and August 2020.

12 Apr 2022

Comparing SARS-CoV-2 Delta and Omicron waves in Germany

In a recent study posted to the medRxiv* preprint server, researchers compared the outcomes and characteristics of hospitalized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients during the SARS-CoV-2 Delta and Omicron variants’ dominant periods in Germany.

12 Apr 2022

Antibody response following Omicron BA.2 infection is lower than BA.1

In a recent report posted to the medRxiv* preprint server, researchers determined immune responses generated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 and BA.1 sublineage infections in prior virus-infected and naïve subjects.

12 Apr 2022